Viemed Healthcare (VMD) Earnings Analysis
Viemed Healthcare (VMD) has no confirmed upcoming earnings date. Last quarter (2026-03-04) it beat with EPS 0.14 USD vs 0.12 USD est (+16.7%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 30.79.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VMD next report earnings?
No confirmed upcoming earnings date is currently scheduled for VMD. This page updates as the calendar is published.
VMD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-04 | 0.14 USD | 0.12 USD | +16.7% | Beat |
| 2025-03-10 | 0.1 USD | 0.11 USD | -9.1% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
VMD valuation and analyst view
| Trailing P/E | 30.79 |
|---|---|
| Trailing EPS | 0.3875 USD |
| Price / book | 3.18 |
| Dividend yield | 0.00% |
| Market cap | 0.46B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Viemed Healthcare (VMD)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for VMD. This page updates as the calendar is published.
Did VMD beat earnings last quarter?
In its 2026-03-04 report, VMD posted EPS of 0.14 USD versus a 0.12 USD estimate — a beat of 16.7%.
What is VMD's earnings track record?
Over the last 2 reported quarters with consensus data, VMD beat estimates 1 times (50%).
What is VMD's current P/E ratio and EPS?
VMD trades at a trailing P/E of 30.79 on trailing EPS of 0.38749797416444237 USD.
What do analysts rate VMD?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).